You Mi-Hyeon
Department of Anatomy, Konkuk University College of Medicine, 50-1, 268 Chungwon-daero, Cungju-si 27478, Republic of Korea.
Curr Issues Mol Biol. 2024 Jul 5;46(7):7086-7096. doi: 10.3390/cimb46070422.
Death-associated protein kinase 1 (DAPK1) is a calcium/calmodulin (Ca/CaM)-dependent serine/threonine (Ser/Thr) protein kinase and is characteristically downregulated in metastatic cancer. Several studies showed that DAPK1 is involved in both the early and late stages of cancer. DAPK1 downregulation is elaborately controlled by epigenetic, transcriptional, posttranscriptional, and posttranslational processes. DAPK1 is known to regulate not only cancer cells but also stromal cells. Recent studies showed that DAPK1 was involved not only in tumor suppression but also in epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) formation in colon and thyroid cancers. CSCs are major factors in determining cancer aggressiveness in cancer metastasis and treatment prognosis by influencing EMT. However, the molecular mechanism involved in the regulation of cancer cells by DAPK1 remains unclear. In particular, little is known about the existence of CSCs and how they are regulated in papillary thyroid carcinoma (PTC) among thyroid cancers. In this review, we describe the molecular mechanism of CSC regulation by DAPK1 in PTC progression.
死亡相关蛋白激酶1(DAPK1)是一种钙/钙调蛋白(Ca/CaM)依赖性丝氨酸/苏氨酸(Ser/Thr)蛋白激酶,其在转移性癌症中通常下调。多项研究表明,DAPK1参与癌症的早期和晚期阶段。DAPK1的下调受到表观遗传、转录、转录后和翻译后过程的精细调控。已知DAPK1不仅调节癌细胞,还调节基质细胞。最近的研究表明,DAPK1不仅参与肿瘤抑制,还参与结肠癌和甲状腺癌中的上皮-间质转化(EMT)和癌症干细胞(CSC)形成。CSC是通过影响EMT来决定癌症转移和治疗预后中癌症侵袭性的主要因素。然而,DAPK1调节癌细胞的分子机制仍不清楚。特别是,在甲状腺癌中,关于乳头状甲状腺癌(PTC)中CSC的存在及其调控方式知之甚少。在本综述中,我们描述了DAPK1在PTC进展中调控CSC的分子机制。